Ra Medical Systems, Inc.
RMED · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| FCF Yield | -497.61% | 0.00% | -370.84% | -354.02% |
| EV / EBITDA | -0.07 | 0.00 | 0.53 | 0.17 |
| Quality | ||||
| ROIC | -53.38% | 0.00% | -290.04% | -183.66% |
| Gross Margin | 90.00% | 0.00% | -1,050.00% | -6,990.91% |
| Cash Conversion Ratio | 0.56 | 0.29 | 0.84 | 1.10 |
| Growth | ||||
| Revenue 3-Year CAGR | 167.27% | -85.30% | -85.49% | -11.04% |
| Free Cash Flow Growth | 54.88% | 8.37% | 19.02% | 1.70% |
| Safety | ||||
| Net Debt / EBITDA | 0.10 | 0.00 | 0.86 | 0.44 |
| Interest Coverage | 123.55 | 0.00 | -8.76 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 1.27 | 0.00 | 3.07 | 1.58 |
| Cash Conversion Cycle | -1,651.19 | 0.00 | 1,880.88 | 347.94 |